United States - English - NLM (National Library of Medicine)

bausch health us llc - phytonadione (unii: a034se7857) (phytonadione - unii:a034se7857) - phytonadione 5 mg - mephyton is indicated for the treatment of adults with the following coagulation disorders which are due to faulty formation of factors ii, vii, ix and x when caused by vitamin k deficiency or interference with vitamin k activity. mephyton is contraindicated in patients with a history of a hypersensitivity reaction to phytonadione or inactive ingredients [see description (11)] . risk summary published studies with the use of phytonadione during pregnancy have not reported a clear association with phytonadione and adverse developmental outcomes [see data]. there are maternal and fetal risks associated with vitamin k deficiency during pregnancy [see clinical considerations]. animal reproduction studies have not been conducted with phytonadione. the estimated background risk for the indicated population is unknown. all pregnancies have a background risk of birth defect, loss, or other adverse outcomes. in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinica

United States - English - NLM (National Library of Medicine)

international medication systems, limited - phytonadione (unii: a034se7857) (phytonadione - unii:a034se7857) - phytonadione 1 mg in 0.5 ml - phytonadione injectable emulsion, usp is indicated for the treatment of the following coagulation disorders which are due to faulty formation of factors ii, vii, ix and x when caused by vitamin k deficiency or interference with vitamin k activity: • anticoagulant-induced hypoprothrombinemia caused by coumarin or indanedione derivatives; • hypoprothrombinemia due to antibacterial therapy; • hypoprothrombinemia secondary to factors limiting absorption or synthesis of vitamin k, e.g., obstructive jaundice, biliary fistula, sprue, ulcerative colitis, celiac     disease, intestinal resection, cystic fibrosis of the pancreas, and regional enteritis; • other drug-induced hypoprothrombinemia where it is definitely shown that the result is due to interference with vitamin k metabolism, e.g., salicylates. phytonadione injectable emulsion, usp is indicated for prophylaxis and treatment of vitamin k-deficiency bleeding in neonates. hypersensitivity to phytonadione or any other component of this medication [see warnings a

United States - English - NLM (National Library of Medicine)

teligent pharma, inc. - phytonadione (unii: a034se7857) (phytonadione - unii:a034se7857) - phytonadione 2 mg in 1 ml - phytonadione is indicated for the treatment of the following coagulation disorders which are due to faulty formation of factors ii, vii, ix and x when caused by vitamin k deficiency or interference with vitamin k activity: - anticoagulant-induced hypoprothrombinemia caused by coumarin or indanedione derivatives; - hypoprothrombinemia due to antibacterial therapy; - hypoprothrombinemia secondary to factors limiting absorption or synthesis of vitamin k, e.g., obstructive jaundice, biliary fistula, sprue, ulcerative colitis, celiac disease, intestinal resection, cystic fibrosis of the pancreas, and regional enteritis; - other drug-induced hypoprothrombinemia where it is definitely shown that the result is due to interference with vitamin k metabolism, e.g., salicylates. phytonadione is indicated for prophylaxis and treatment of vitamin k-deficiency bleeding in neonates. hypersensitivity to phytonadione or any other component of this medication. [see warnings and precautions (5.1)]. risk summary   phytonadione c

United States - English - NLM (National Library of Medicine)

rebel distributors corp - phytonadione (unii: a034se7857) (phytonadione - unii:a034se7857) - phytonadione 5 mg - mephyton is indicated in the following coagulation disorders which are due to faulty formation of factors ii, vii, ix and x when caused by vitamin k deficiency or interference with vitamin k activity. mephyton tablets are indicated in: - anticoagulant-induced prothrombin deficiency caused by coumarin or indanedione derivatives; - hypoprothrombinemia secondary to antibacterial therapy; - hypoprothrombinemia secondary to administration of salicylates; - hypoprothrombinemia secondary to obstructive jaundice or biliary fistulas but only if bile salts are administered concurrently, since otherwise the oral vitamin k will not be absorbed. hypersensitivity to any component of this medication.

United States - English - NLM (National Library of Medicine)

physicians total care, inc. - phytonadione (unii: a034se7857) (phytonadione - unii:a034se7857) - phytonadione 5 mg - mephyton is indicated in the following coagulation disorders which are due to faulty formation of factors ii,vii, ix and x when caused by vitamin k deficiency or interference with vitamin k activity. mephyton tablets are indicated in: hypersensitivity to any component of this medication.

United States - English - NLM (National Library of Medicine)

general injectables & vaccines, inc - phytonadione (unii: a034se7857) (phytonadione - unii:a034se7857) - phytonadione 1 mg in 0.5 ml - 1.1 treatment of hypoprothrombinemia due to vitamin k deficiency or interference phytonadione injectable emulsion, usp is indicated for the treatment of the following coagulation disorders which are due to faulty formation of factors ii, vii, ix and x when caused by vitamin k deficiency or interference with vitamin k activity; - anticoagulant-induced hypoprothrombinemia caused by coumarin or indanedione derivatives; - hypoprothrombinemia due to antibacterial therapy; - hypoprothrombinemia secondary to factors limiting absorption or synthesis of vitamin k, e.g., obstructive jaundice, biliary fistula, sprue, ulcerative colitis, celiac disease, intestinal resection, cystic fibrosis of the pancreas, and regional enteritis; - other drug-induced hypoprothrombinemia where it is definitely shown that the result is due to interference with vitamin k metabolism, e.g., salicylates. 1.2 prophylaxis and treatment of vitamin k-deficiency bleeding in neonates phytonadione injectable emulsion, usp is indicated for prophylaxi

United States - English - NLM (National Library of Medicine)

carilion materials management - phytonadione (unii: a034se7857) (phytonadione - unii:a034se7857) - phytonadione 5 mg - mephyton is indicated in the following coagulation disorders which are due to faulty formation of factors ii,vii, ix and x when caused by vitamin k deficiency or interference with vitamin k activity. mephyton tablets are indicated in: hypersensitivity to any component of this medication.

United States - English - NLM (National Library of Medicine)

allermed laboratories, inc. - trichophyton mentagrophytes (unii: 199i7j3jiv) (trichophyton mentagrophytes - unii:199i7j3jiv), trichophyton rubrum (unii: 2zau32517n) (trichophyton rubrum - unii:2zau32517n) - trichophyton mentagrophytes 1 g in 1000 ml - intradermal skin tests with trichophyton extract are indicated for use in persons who are suspected of having type i hypersensitivity (i.e. allergy) to the fungus. conditions under which the administration of allergenic extract may be contraindicated, depending upon individual circumstances, include: extreme sensitivity to an allergen - determined from the allergic history, or from previous anaphylaxis following skin testing or subcutaneous injection; myocardial infarction - patients who have experienced a recent myocardial infarction may be less able to tolerate the life-threatening effects of a serious adverse reaction. asthma - patients with highly unstable asthma are at greater risk of fatal reactions from skin tests than are patients without asthma, especially during seasonal exacerbations of the disease. also, the combination of unstable asthma and treatment with b-adrenergic blockers appears to increase this risk5 . allergenic extract should be temporarily withheld from patients if any of the followin

United States - English - NLM (National Library of Medicine)

cardinal health - phytonadione (unii: a034se7857) (phytonadione - unii:a034se7857) - phytonadione 5 mg

United States - English - NLM (National Library of Medicine)

kaiser foundation hospitals - phytonadione (unii: a034se7857) (phytonadione - unii:a034se7857) - phytonadione 5 mg